⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918641 | 0.82 | — | — | |
| SCHEMBL50767 | 0.82 | — | — | |
| SCHEMBL2167614 | 0.78 | TSHR (0.50) | — | |
| Hydrochloric Acid SCHEMBL11801806 | 0.78 | — | — | |
| SCHEMBL11308176 | 0.78 | — | — | |
| SCHEMBL4593374 | 0.78 | TDP1 (0.31) | — | |
| SCHEMBL11559335 | 0.78 | TSHR (0.50) | — | |
| SCHEMBL918953 | 0.78 | TDP1 (0.31) | — | |
| SCHEMBL11559954 | 0.78 | TSHR (0.50) | — | |
| SCHEMBL11308174 | 0.78 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2424487-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | Ahlstrom Corporation (FI) | 2012-03-07 | — | — | EP | claimed |
| WO-2010125239-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2010-11-04 | — | — | WO | claimed |
| US-20140341909-A1 | CONJUGATION OF BIOMOLECULES USING DIELS-ALDER CYCLOADDITION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV (US) | 2014-11-20 | — | — | US | disclosed |
| EP-2424487-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | Ahlstrom Corporation (FI) | 2012-03-07 | — | — | EP | disclosed |
| US-7910611-B2 | Therapeutic agent for restenosis | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-03-22 | — | — | US | disclosed |
| WO-2010125239-A2 | CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES | AHLSTROM CORPORATION (FI) | 2010-11-04 | — | — | WO | disclosed |
| US-20100209448-A1 | SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES | THERACARB, INC. | 2010-08-19 | — | — | US | disclosed |
| US-7722890-B2 | Synthetic anti-Candida albicans oligosaccharide based vaccines | THERACARB, INC. (CA) | 2010-05-25 | — | — | US | disclosed |
| US-20100029625-A1 | Therapeutic Agent for Restenosis | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| US-7479254-B2 | Application using non-covalent bond between a cucurbituril derivative and a ligand | POSTECH FOUNDATION (KR) | 2009-01-20 | — | — | US | disclosed |
| US-20080262049-A1 | Therapeutic Agent for Hematopoietic Tumor | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| WO-2002048163-A2 | PROCESSES FOR THE PREPARATION OF αGAL(1→4)βGAL(1→4)GLC-OR TRISACCHARIDES | SYNSORB BIOTECH, INC. (CA) | 2002-06-20 | — | — | WO | disclosed |
| US-20020068818-A1 | Conjugation of biomolecules using diels-alder cycloaddition | POZSGAY VINCE (US) | 2002-06-06 | — | — | US | disclosed |
| WO-2002044190-A2 | PROCESSES FOR THE PREPARATION OF αGal(1→3)βGal(1→4)Glc-OR | SYNSORB BIOTECH, INC. (CA) | 2002-06-06 | — | — | WO | disclosed |
| US-20020051788-A1 | For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines | HEALTH AND HUMAN SERVICES, DEPARTMENT OF, GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, THE | 2002-05-02 | — | — | US | disclosed |
| US-5910579-A | Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR | SYNSORB BIOTECH INC. (CA) | 1999-06-08 | — | — | US | disclosed |
| WO-1998030572-A1 | PROCESSES FOR THE PREPARATION OF αGal(1→4)βGal(1→4)Glc-OR | SYNSORB BIOTECH, INC. (CA) | 1998-07-16 | — | — | WO | disclosed |
| EP-0517743-A1 | IMPROVED IMMUNOGENIC COMPOSITIONS | ALBERTA RESEARCH COUNCIL (CA) | 1992-12-16 | — | — | EP | disclosed |
| WO-1991012819-A1 | IMPROVED IMMUNOGENIC COMPOSITIONS | ALBERTA RESEARCH COUNCIL (CA) | 1991-09-05 | — | — | WO | disclosed |
| US-5043158-A | Immunogenic compositions containing ordered carriers | CHEMBIOMED, LTD. (CA) | 1991-08-27 | — | — | US | disclosed |